Literature DB >> 24249252

Long-term outcome following surgical treatment of sacral chordoma.

Shunzo Osaka1, Eiji Osaka, Toshio Kojima, Yukihiro Yoshida, Yasuaki Tokuhashi.   

Abstract

BACKGROUND: Sixteen sacral chordoma surgeries performed at a single institution during the 1983-2008 period were retrospectively studied. Our aim is to assess surgical treatment and long-term outcomes.
METHODS: Fifteen patients underwent primary wide excision, and one intralesional excision using ethanol for local control and radiation therapy (RT). A combined anteroposterior approach for large tumors above S2, and wide excision was performed with the modified threadwire-saw (MT-saw) after 1997.
RESULTS: Fourteen of the 15 patients had wide margins, one a wide margin with contamination. The MT-saw was facilitated sacral excision with wide margins. Eleven patients are alive for 5-28 years. Five patients died before 10 years, two patients experienced sepsis, and one of another disease. Two patients died of local recurrence (LR) and another of multiple metastases after intralesional excision and wide excision with contamination, respectively. LR and complications occurred 4 each of 11 patients with tumors ≥ 10 cm, neither with tumors < 10 cm. The overall 5- and 10-year survival rate with wide surgical margins was 13/16 (81.3%) and 8/13 (61.5%).
CONCLUSIONS: A combined anteroposterior approach for large tumors, and the MT-saw facilitates sacral excision with wide margins. Wide excision is recommended for younger patients.
© 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  long-term outcome; sacral chordoma; surgical treatment

Mesh:

Year:  2013        PMID: 24249252     DOI: 10.1002/jso.23490

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  10 in total

Review 1.  Health-Related Quality of Life After Spine Surgery for Primary Bone Tumour.

Authors:  Raphaële Charest-Morin; Nicolas Dea; Charles G Fisher
Journal:  Curr Treat Options Oncol       Date:  2016-02

Review 2.  Comparison of combined anterior-posterior and posterior-only approaches for lumbosacral chordomas: a systematic review and meta-analysis of surgical and clinical outcomes.

Authors:  Quintino Giorgio D'Alessandris; Martina Offi; Valerio Maria Caccavella; Martina Giordano; Eduardo Fernandez; Liverana Lauretti; Roberto Pallini; Alessandro Olivi; Nicola Montano
Journal:  Neurosurg Rev       Date:  2022-02-19       Impact factor: 3.042

3.  Clinical features and prognostic factors of patients with chordoma in the spine: a retrospective analysis of 153 patients in a single center.

Authors:  Tong Meng; Huabin Yin; Bo Li; Zhenxi Li; Wei Xu; Wang Zhou; Mo Cheng; Jing Wang; Lei Zhou; Xinghai Yang; Tielong Liu; Wangjun Yan; Dianwen Song; Jianru Xiao
Journal:  Neuro Oncol       Date:  2014-12-08       Impact factor: 12.300

4.  What Are the Conditional Survival and Functional Outcomes After Surgical Treatment of 115 Patients With Sacral Chordoma?

Authors:  Tao Ji; Wei Guo; Rongli Yang; Xiaodong Tang; Yifei Wang; Lin Huang
Journal:  Clin Orthop Relat Res       Date:  2017-03       Impact factor: 4.176

5.  How Does the Level of Nerve Root Resection in En Bloc Sacrectomy Influence Patient-Reported Outcomes?

Authors:  Olivier D R van Wulfften Palthe; Matthew T Houdek; Peter S Rose; Michael J Yaszemski; Franklin H Sim; Patrick J Boland; John H Healey; Francis J Hornicek; Joseph H Schwab
Journal:  Clin Orthop Relat Res       Date:  2017-03       Impact factor: 4.176

6.  Surgical management of chordoma: A systematic review.

Authors:  Luca Denaro; Alessandra Berton; Mauro Ciuffreda; Mattia Loppini; Vincenzo Candela; Maria Luisa Brandi; Umile Giuseppe Longo
Journal:  J Spinal Cord Med       Date:  2018-07-26       Impact factor: 1.985

7.  MicroRNA-155 expression is independently predictive of outcome in chordoma.

Authors:  Eiji Osaka; Andrew D Kelly; Dimitrios Spentzos; Edwin Choy; Xiaoqian Yang; Jacson K Shen; Pei Yang; Henry J Mankin; Francis J Hornicek; Zhenfeng Duan
Journal:  Oncotarget       Date:  2015-04-20

Review 8.  Recent advances in understanding and managing chordomas.

Authors:  Carl Youssef; Salah G Aoun; Jessica R Moreno; Carlos A Bagley
Journal:  F1000Res       Date:  2016-12-22

Review 9.  Local and Distant Recurrence in Resected Sacral Chordomas: A Systematic Review and Pooled Cohort Analysis.

Authors:  Daniel Kerekes; C Rory Goodwin; A Karim Ahmed; Jorrit-Jan Verlaan; Chetan Bettegowda; Nancy Abu-Bonsrah; Daniel M Sciubba
Journal:  Global Spine J       Date:  2018-05-30

10.  Lymphocyte-Related Inflammation and Immune-Based Scores Predict Prognosis of Chordoma Patients After Radical Resection.

Authors:  Wenhao Hu; Jiayi Yu; Yong Huang; Fanqi Hu; Xuesong Zhang; Yan Wang
Journal:  Transl Oncol       Date:  2018-02-22       Impact factor: 4.243

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.